Post job

Biohaven Pharmaceuticals's revenue is $462.5 million.

What is Biohaven Pharmaceuticals's revenue?

Biohaven Pharmaceuticals's annual revenue is $462.5M. Zippia's data science team found the following key financial metrics about Biohaven Pharmaceuticals after extensive research and analysis.
  • Biohaven Pharmaceuticals's revenue growth from 2020 to 2021 is 626.91%.
  • Biohaven Pharmaceuticals has 825 employees, and the revenue per employee ratio is $560,616.
  • Biohaven Pharmaceuticals's peak quarterly revenue was $92.9M in 2021(q2).
  • Biohaven Pharmaceuticals peak revenue was $462.5M in 2021.
  • Biohaven Pharmaceuticals annual revenue for 2021 was 462.5M, 626.91% growth from 2020.

On this page

Most recent quarter revenue
$92.9M (Q2'2021)
Company most recent quarter revenue
Peak revenue
$462.5M (2021)
Company peak revenue
Revenue / employee
$560,617
Company revenue / employee

Zippia finds jobs where you're a top candidate and applies on your behalf.

Floating question marks illustration
Most recent quarter revenue
$92.9M (Q2'2021)
Company most recent quarter revenue
Peak revenue
$462.5M (2021)
Company peak revenue
Revenue / employee
$560,617
Company revenue / employee

Biohaven Pharmaceuticals financial information

CEOVladimir Coric
IndustrySoftware & Services
Company TypePublic
Employees Number825
Date Founded2013
HeadquartersNew Haven, Connecticut
Number of Locations1
Revenue$462.5M
Net Income-$846,586,000
Gross Proft$370.8M (2021)
Tax Rate-0.0%
Total Assets$1,077,212,000
TickerBHVN

Biohaven Pharmaceuticals jobs you might like

Biohaven Pharmaceuticals financing

Biohaven Pharmaceuticals received early financing of $80.0M on 2016-11-01.

SeriesRound sizeDate
Series Unknown$80M11/2016
Series Unknown$20M03/2017
Post Ipo Equity$143.7M12/2018
Post Ipo Equity$200M03/2021

Biohaven Pharmaceuticals investors

InvestorsSecurity type
Gregory BaileySeries Unknown
Connecticut InnovationsSeries Unknown
Knoll Capital ManagementSeries Unknown
Osage University PartnersSeries Unknown
VenrockSeries Unknown
Vivo CapitalSeries Unknown
Litmore CapitalSeries Unknown
John W. ChildsSeries Unknown
Aperture Venture PartnersSeries Unknown
RA Capital ManagementSeries Unknown
Rock Springs CapitalSeries Unknown
Aisling CapitalSeries Unknown

Biohaven Pharmaceuticals revenue FAQs

Search for jobs

Zippia gives an in-depth look into the details of Biohaven Pharmaceuticals, including salaries, political affiliations, employee data, and more, in order to inform job seekers about Biohaven Pharmaceuticals. The employee data is based on information from people who have self-reported their past or current employments at Biohaven Pharmaceuticals. The data on this page is also based on data sources collected from public and open data sources on the Internet and other locations, as well as proprietary data we licensed from other companies. Sources of data may include, but are not limited to, the BLS, company filings, estimates based on those filings, H1B filings, and other public and private datasets. While we have made attempts to ensure that the information displayed are correct, Zippia is not responsible for any errors or omissions or for the results obtained from the use of this information. None of the information on this page has been provided or approved by Biohaven Pharmaceuticals. The data presented on this page does not represent the view of Biohaven Pharmaceuticals and its employees or that of Zippia.

Biohaven Pharmaceuticals may also be known as or be related to BIOHAVEN PHARMACEUTICAL HOLDING CO LTD, Biohaven Pharmaceutical, Biohaven Pharmaceutical Holding Co Ltd., Biohaven Pharmaceutical Holding Company Ltd, Biohaven Pharmaceutical Holding Company Ltd., Biohaven Pharmaceuticals, Biohaven Pharmaceuticals Inc. and Biohaven Pharmaceuticals, Inc.